News

15
Sep

Positron Announces Timeline for Becoming Current with its OTC Reporting & Disclosures 

Niagara Falls, NY – September 14, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC) is pleased to announce that Positron has received full OTCIQ access for its filing and approval process with OTC... Read More

15
Jul

Positron Retains Healthcare Advisor I-Square Ventures to Implement Strategy and Expand Market Share

Niagara Falls, NY – July 15, 2021 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC) is pleased to announce today that it has retained the services of I- Square Ventures (“I-Square”)... Read More

13
Apr

Q1 2021 Update

April 12, 2021

Re: Q1 2021 Update

Dear Positron Shareholders,

As announced last month we are pleased to have retained Skyline Corporate Communications Group as Positron’s investor relations liaison. Skyline will play a large role in our corporate communication efforts to introduce and inform new, perspective... Read More

26
Mar

Positron Update March 2020

March 24, 2020

Dear Positron Shareholders,

On behalf of our investors and supporters we are pleased to offer some forward guidance to our business.

The cardiac PET industry is healthy and in the best position we have seen in a decade. A great deal of the industry’s vision and best practices come from the... Read More

27
Feb

PET scans help visualize mechanisms behind nerve damage common among Parkinson’s patients, could help diagnose the disease earlier.

 

Full Text

19
Feb

Series of Johns Hopkins studies reveal clumping of protein desmin could be used as diagnostic tool for testing therapies or disease progression.

 

Full Text